Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Alannah Smrke"'
Autor:
J. Robert Beecroft, Savtaj Brar, Xiaolan Feng, Trevor Hamilton, Cheng Han-Lee, Jan-Willem Henning, P. David Josephy, Korosh Khalili, Yoo-Joung Ko, Christopher Lemieux, David M. Liu, D. Blair MacDonald, Jonathan Noujaim, Aaron Pollett, Abdulazeez Salawu, Ramy Saleh, Alannah Smrke, Blair E. Warren, Kevin Zbuk, Albiruni Abdul Razak
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Gastrointestinal stromal tumours (GISTs) are mesenchymal tumours that originate from the interstitial cells of Cajal. GISTs are mainly driven by gain-of-function mutations in receptor tyrosine kinase or platelet-derived growth factor receptor alpha.
Externí odkaz:
https://doaj.org/article/73ebf25c2ec54ada94f29107610fcdf0
Autor:
Hagit Peretz Soroka, Tushar Vora, Jonathan Noujaim, Nicolas Marcoux, Sarah Cohen‐Gogo, Thierry Alcindor, Caroline Holloway, Caroline Rodrigues, Hatim Karachiwala, Saima Alvi, Ursula Lee, Sylvia Cheng, Shantanu Banerji, Sapna Oberoi, Xiaolan Feng, Alannah Smrke, Christine Simmons, Albiruni Abdul Razak, Abha A. Gupta
Publikováno v:
Cancer Medicine, Vol 12, Iss 18, Pp 18872-18881 (2023)
Abstract Objectives We conducted a retrospective multi‐centre study to assess the real‐world outcome of regorafenib (REGO) and cabozantinib (CABO) in recurrent/refractory bone tumours (BTs) including osteosarcoma (OST), Ewing sarcoma (EWS) and ch
Externí odkaz:
https://doaj.org/article/77f0759b62cf455bb618ca80b59f6638
Autor:
Holly M. McCabe, Alannah Smrke, Fiona Cowie, Jeff White, Peter Chong, Steven Lo, Ashish Mahendra, Sanjay Gupta, Michelle Ferguson, David Boddie, Walter Mmekka, Lorraine Stirling, Lindsay Campbell, Robin L. Jones, Ioanna Nixon
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 1067-1073 (2021)
PURPOSEIn Scotland, approximately 350 sarcoma cases are diagnosed per year and treated in one of the five specialist centers. Many patients are required to travel long distances to access specialist care. The COVID-19 pandemic brought a number of rap
Externí odkaz:
https://doaj.org/article/b20a86c6025046f7b881ed986b513fca
Publikováno v:
Diagnostics, Vol 13, Iss 11, p 1973 (2023)
Due to the rarity and complexity of treatment for Ewing sarcoma and rhabdomyosarcoma, studies demonstrate improved patient outcomes when managed by a multidisciplinary team at high-volume centres (HVCs). Our study explores the difference in outcomes
Externí odkaz:
https://doaj.org/article/63ecbf73e3354f0eae30f4bfdff4627c
Autor:
Anna M. Frezza, Vinod Ravi, Salvatore Lo Vullo, Bruno Vincenzi, Francesco Tolomeo, Tom Wei‐Wu Chen, Pawel Teterycz, Giacomo G. Baldi, Antoine Italiano, Nicolas Penel, Antonella Brunello, Florance Duffaud, Nadia Hindi, Shintaro Iwata, Alannah Smrke, Alexander Fedenko, Hans Gelderblom, Winette Van Der Graaf, Aurore Vozy, Elizabeth Connolly, Massimiliano Grassi, Robert S. Benjamin, Javier‐Martin Broto, Giovanni Grignani, Robin L. Jones, Akira Kawai, Andrzej Tysarowski, Luigi Mariani, Paolo G. Casali, Silvia Stacchiotti
Publikováno v:
Cancer Medicine, Vol 10, Iss 8, Pp 2645-2659 (2021)
Abstract Background This observational, retrospective effort across Europe, US, Australia, and Asia aimed to assess the activity of systemic therapies in EHE, an ultra‐rare sarcoma, marked by WWTR1‐CAMTA1 or YAP1‐TFE3 fusions. Methods Twenty sa
Externí odkaz:
https://doaj.org/article/56e3c27fbb994c9fa4bc5bb179921864
Autor:
Alannah Smrke, Eugenie Younger, Roger Wilson, Olga Husson, Sheima Farag, Eve Merry, Aislinn Macklin-Doherty, Elena Cojocaru, Amani Arthur, Charlotte Benson, Aisha B. Miah, Shane Zaidi, Spyridon Gennatas, Robin L. Jones
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 1046-1051 (2020)
PURPOSEMany patients with cancer, often those with rare cancers such as sarcomas, travel long distances to access expert care. The COVID-19 pandemic necessitated widespread changes in delivery of cancer care, including rapid adoption of telemedicine-
Externí odkaz:
https://doaj.org/article/c0cf328f17ad4344ac597766a7890ef8
Publikováno v:
Journal of Bone Oncology, Vol 31, Iss , Pp 100400- (2021)
Osteosarcoma is a rare, primary tumour of bone. Curative treatment consists of multi-agent chemotherapy and complete surgical resection. Despite the use of multi-agent chemotherapy, the risk of recurrence is high. Survival outcomes for patients with
Externí odkaz:
https://doaj.org/article/ed924d8a581840bbb5f294c672b0c6d2
Publikováno v:
Sarcoma, Vol 2019 (2019)
Introduction. Information on the psychosocial distress and needs of sarcoma patients at diagnosis is sparse. The Canadian Problem Checklist (CPC) and Psychosocial Screen for Cancer-Revised (PSSCAN-R) are validated tools to identify cancer patients’
Externí odkaz:
https://doaj.org/article/073564ecdf8b4c789f4321cd2c62c981
Autor:
Alannah Smrke, Peter M. Anderson, Ashish Gulia, Spyridon Gennatas, Paul H. Huang, Robin L. Jones
Publikováno v:
Cells, Vol 10, Iss 1, p 172 (2021)
Osteosarcoma is the most common primary bone sarcoma and is often diagnosed in the 2nd–3rd decades of life. Response to the aggressive and highly toxic neoadjuvant methotrexate-doxorubicin-cisplatin (MAP) chemotherapy schedule is strongly predictiv
Externí odkaz:
https://doaj.org/article/7901e56b12b84c2daaa62156325ade31
Autor:
Alannah Smrke, Peter L. Gross
Publikováno v:
Frontiers in Medicine, Vol 4 (2017)
Patients with cancer are at significantly higher risk of developing, and dying from, venous thromboembolism (VTE). The CLOT trial demonstrated superiority of low-molecular-weight heparins (LMWH) over warfarin for recurrent VTE and established LMWH as
Externí odkaz:
https://doaj.org/article/69b4ac18613a4c5190441edbd7156bc1